Robin Kate Kelley
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Sorafenib and Nivolumab in Treating Participants With Unresectable, Locally Advanced or Metastatic Liver Cancer (NCT03439891) | Robin Kate Kelley | 2018-04-16 |
| Pembrolizumab and GM-CSF in Biliary Cancer (NCT02703714) | Robin Kate Kelley | 2016-05-06 |
Track Robin Kate Kelley automatically
Every clearance here is in the API, with alerts when new ones post.